White Paper · 2026
The record of the 2026 Global Cannabis Regulatory Summit, held in London, United Kingdom on 19–21 April 2026. Organised around the Summit’s core pillars, Standards and Responsibility, it builds on the 2025 White Paper and sets out the priorities and next steps that shape the 2027 Summit in Zürich.
Complete the form below and you will see a link to download the white paper directly.
DownloadOverview
The international discussion surrounding cannabis regulation has evolved considerably in recent years. What was once viewed primarily through the lens of criminal enforcement or domestic political debate is increasingly being addressed as a matter of public health, patient care, scientific rigour, and regulatory governance.
Convened in London, the 2026 Summit brought together participants representing nearly 30 countries and 20 regulatory jurisdictions for practical, forward-looking dialogue on the governance frameworks, scientific standards, operational safeguards, and coordination mechanisms required to support credible and responsible cannabis oversight across both established and emerging regulatory environments.
The white paper reflects perspectives from regulators, policymakers, physicians, researchers, patients and patient advocates, standards experts, and legal practitioners. Its findings are offered not as conclusions but as a continuation of the process of learning and coordination that began at the 2025 Summit in Washington, D.C., and that carries into the 2027 Summit in Zürich.
Key Findings
As health-related cannabis programmes expand, inconsistencies in technical standards, regulatory terminology, compliance frameworks, and product oversight continue to fragment markets and limit reliable cross-border systems, affecting regulators, healthcare providers, and patients alike.
Sustainable confidence in regulated systems depends on transparent oversight, disciplined compliance practices, reliable data systems, and governance structures capable of supporting long-term public health objectives.
Trust remains central to the future of cannabis regulation: between governments and regulators, between healthcare providers and patients, and in regulated systems meeting accepted standards of safety, quality, and accountability.
Agreed technical standards, market responsibility, and a pathway toward greater global regulatory alignment emerged as mutually reinforcing pillars for addressing the fragmentation, inconsistency, and accountability challenges facing global cannabis markets.
Download
Complete the form and a download link will appear immediately.
London, United Kingdom · 19–21 April 2026